Quick Takeaways
- Glen C. MacDonald has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $234,165.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Glen C. MacDonald
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Glen C. MacDonald is at least $234,165 dollars as of 06 Mar 2023. Glen C. MacDonald is the Chief Technology Officer of Sesen Bio, Inc. and owns shares of Carisma Therapeutics Inc. (CARM) stock worth about $234.2K.
- Signature
- /s/ Richard F. Fitzgerald
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Glen C. MacDonald and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Sesen Bio, Inc. ($234,165).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Glen C. MacDonald
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CARM | Sesen Bio, Inc. | Chief Technology Officer | $234,165 | 02 Mar 2023 |
Insider Transactions Reported by Glen C. MacDonald:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.